-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Morgan Stanley Maintains Equal-Weight on Pulmonx, Lowers Price Target to $9.5

Benzinga · 01/06/2023 10:15
Morgan Stanley analyst Cecilia Furlong maintains Pulmonx (NASDAQ:LUNG) with a Equal-Weight and lowers the price target from $14 to $9.5.